Here is a news article on how the biotech sector is getting funding from investors. ACL is not mentioned but you get the picture that if ACL gets a good trial outcome the oncology listing could go ahead or we can get a big deal. Had Pete Smith not proceeded with the oncology listing on 2012, he would have still been the CEO now. It was really bad timing forced by big shareholders.
http://www.brisbanetimes.com.au/business/how-biotech-finally-boomed-20140103-309jk.html
Not so many Australian biotechs with Phase III results coming out soon.
- Forums
- ASX - By Stock
- good news for the chemo reformulation space
Here is a news article on how the biotech sector is getting...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable